DB19000InvestigationalProtein Based Therapies
Nelmastobart is under investigation in clinical trial NCT05990543 (Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer).
- Code names
- hSTC-810
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Nelmastobart, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account